Evaluation of the nonsteroidal anti-inflammatory drug-sparing effect of etanercept in axial spondyloarthritis: results of the multicenter, randomized, double-blind, placebo-controlled SPARSE study

Effectiveness of Tumor Necrosis Factor α Blockers in Early Axial Spondyloarthritis: Data From the DESIR Cohort

(2014) Anna Moltó et al.   Arthritis & Rheumatology

Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study

(2013) R Landewé et al.   ANNALS OF THE RHEUMATIC DISEASES

Cigarette smoking has a dose-dependent impact on progression of structural damage in the spine in patients with axial spondyloarthritis: results from the GErman SPondyloarthritis Inception Cohort (GESPIC)

(2013) Denis Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort

(2013) Adrian Ciurea et al.   ARTHRITIS AND RHEUMATISM

Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial

(2012) In-Ho Song et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)

(2012) Joachim Sieper et al.   ANNALS OF THE RHEUMATIC DISEASES

ASAS recommendations for variables to be collected in clinical trials/epidemiological studies of spondyloarthritis: Figure 1

(2012) Maxime Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis

(2012) Féline Kroon et al.   ANNALS OF THE RHEUMATIC DISEASES

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort

(2012) Denis Poddubnyy et al.   ANNALS OF THE RHEUMATIC DISEASES

Sensitivity and discriminatory ability of the Ankylosing Spondylitis Disease Activity Score in patients treated with etanercept or sulphasalazine in the ASCEND trial

(2012) D. van der Heijde et al.   RHEUMATOLOGY

Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

(2012) Uta Kiltz et al.   ARTHRITIS CARE & RESEARCH

Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE)

(2011) M. Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis

(2011) J. Braun et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical efficacy and safety of etanercept versus sulfasalazine in patients with ankylosing spondylitis: A randomized, double-blind trial

(2011) Juergen Braun et al.   ARTHRITIS AND RHEUMATISM

Spondyloarthritis

(2011) Maxime Dougados et al.   LANCET

Nonsteroidal antiinflammatory drug intake according to the Assessment of SpondyloArthritis International Society Score in clinical trials evaluating tumor necrosis factor blockers: Example of etanercept in advanced ankylosing spondylitis

(2011) Maxime Dougados et al.   ARTHRITIS CARE & RESEARCH

ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis

(2010) M. Dougados et al.   ANNALS OF THE RHEUMATIC DISEASES

An Evidence-Based Review of the Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs

(2009) Michael E. Farkouh et al.   AMERICAN JOURNAL OF CARDIOLOGY

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

Defining active sacroiliitis on magnetic resonance imaging (MRI) for classification of axial spondyloarthritis: a consensual approach by the ASAS/OMERACT MRI group

(2009) M Rudwaleit et al.   ANNALS OF THE RHEUMATIC DISEASES

The early disease stage in axial spondylarthritis: Results from the german spondyloarthritis inception cohort

(2009) Martin Rudwaleit et al.   ARTHRITIS AND RHEUMATISM

Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use

(2009) Sebastian Straube et al.   BMC GASTROENTEROLOGY

Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein

(2009) M. Benhamou et al.   RHEUMATOLOGY

Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations

(2008) I H Song et al.   ANNALS OF THE RHEUMATIC DISEASES

ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis

(2008) D van der Heijde et al.   ANNALS OF THE RHEUMATIC DISEASES

Evaluation of the patient acceptable symptom state as an outcome measure in patients with ankylosing spondylitis: Data from a randomized controlled trial

(2008) Maxime Dougados et al.   ARTHRITIS AND RHEUMATISM